Actinium Stock Forum

$Actinium(ATNM.US)$
NEWS
Actinium Highlights Ability of Iomab-B to Overcome High-Risk TP53 Mutation Resulting in Significant Improvement in Overall Survival in Patients with Active Relapsed Refractory AML at the European Bone Marrow Transplant Annual Meeting

$Actinium(ATNM.US)$ Actinium Pharmaceuticals Granted U.S. Patent #11844799: Method for Treating Cancer Using a BCL-2 Inhibitor in Conjunction With an Alpha-emitting Radioimmunotherapeutic

$Actinium(ATNM.US)$ Actinium to Highlight Broad Potential of Targeted Radiotherapies Iomab-B and Actimab-A for Relapsed or Refractory and Elderly Acute Myeloid Leukemia Patients at the 65th ASH Annual Meeting & Exposition
PR Newswire· 1 min ago

$Actinium(ATNM.US)$ Ionetix to provide Bayer with Therapeutic Radioisotope Actinium-225 (Ac-225)
3 MINUTES AGO, 6:00 AM EST
VIA PR NEWSWIRESHARE
LANSING, Mich., Nov. 15, 2023 /PRNewswire/ -- Ionetix Corporation today announced the signing of a supply agreement for the therapeutic radioisotope actinium-225 (Ac-225) with Bayer. Under the terms of the agreement, Ionetix will provide Bayer with high-purity, non-carrier added (n.c.a.) Ac-225.

$Actinium(ATNM.US)$ Actinium Announces NIH Grant Extension to Advance Clinical Development of Next-Generation CD45 Targeted Conditioning Agent Iomab-ACT with Memorial Sloan Kettering's CAR-T Cell Therapy

$Actinium(ATNM.US)$ ??

🎃
$Arch Capital(ACGL.US)$$Aeglea BioTherapeutics(AGLE.US)$$Actinium(ATNM.US)$$Avis Budget(CAR.US)$$Cardio Diagnostics(CDIO.US)$$1847 Holdings(EFSH.US)$  $Etsy Inc(ETSY.US)$$Getty Images(GETY.US)$$NXP Semiconductors(NXPI.US)$$Tilray Brands(TLRY.US)$$Varonis Systems(VRNS.US)$